Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 14, 2005; 11(26): 3980-3984
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.3980
Published online Jul 14, 2005. doi: 10.3748/wjg.v11.i26.3980
Table 3 Inhibition of the growth of human hepatoma BEL-7402 xenografts by LDM and MMC in athymic mice
| Groups | Dose(mg/kg) | Number of mice(begin/end) | BWC (g) | Tumor volume(mm3) | Inhibitionrate (%) |
| Control | 6/6 | -0.1 | 624.7 ± 360.1 | - | |
| LDM | 0.05 | 6/6 | +0.3 | 195.6 ± 94.1 | 68.7a |
| 0.025 | 6/6 | -0.1 | 454.9 ± 302.3 | 27.2 | |
| MMC | 1.25 | 6/6 | -1.5 | 409.1 ± 225.9 | 34.5 |
- Citation: Huang YH, Shang BY, Zhen YS. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. World J Gastroenterol 2005; 11(26): 3980-3984
- URL: https://www.wjgnet.com/1007-9327/full/v11/i26/3980.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i26.3980